Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research & Development Expenses (Details)

v3.22.1
Research & Development Expenses (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Analysis of income and expense [abstract]      
Employee benefits $ 42,877 $ 53,332 $ 36,630
Contractors and consultants expense 3,917 645 14,752
Other 740 734 (177)
Total $ 47,534 $ 54,711 [1] $ 51,205 [1]
[1] Restated to reflect reclassification of certain expense items described in Note 2.